Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04664309 · ClinicalTrials.gov registry record
Understanding Immunity to the COVID-19 Vaccines
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 43
- Enrollment target
NCT04664309: Completed study, sponsored by Stanford University.
NCT04664309 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04664309 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 43 participants
- Enrollment target
Study Summary
The purpose of this study is to test over time immunity to the COVID-19 vaccines. Adults who are receiving COVID-19 vaccines will be invited to participate.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2021-03-26 |
| Est. Completion | 2022-01-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04664309
The ClinicalTrials.gov registry entry for NCT04664309 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT04664309 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04664309 about?
NCT04664309 is a clinical study titled "Understanding Immunity to the COVID-19 Vaccines". The purpose of this study is to test over time immunity to the COVID-19 vaccines. Adults who are receiving COVID-19 vaccines will be invited to participate.
What is the current status of trial NCT04664309?
This trial is currently completed. The enrollment target is 43 participants. The study started on 2021-03-26. Estimated completion is 2022-01-06.
What interventions are being tested in trial NCT04664309?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT04664309?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.